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Abstract
As machine learning (ML) models, trained on real-world datasets, become com-
mon practice, it is critical to measure and quantify their potential biases. In this
paper, we focus on renal failure and compare a commonly used traditional risk
score, Tangri, with a more powerful machine learning model, which has access to
a larger variable set and trained on 1.6 million patients’ EHR data. We will com-
pare and discuss the generalization and applicability of these two models, in an
attempt to quantify biases of status quo clinical practice, compared to ML-driven
models.
1 Introduction
Data-driven models have become more common in the U.S. healthcare field as their use in clinical
operations and diagnosing procedures have expanded exponentially. The ever-increasing processing
power of machine-learning algorithms allows automatic analysis of huge quantities of data, theoret-
ically maximizing the efficiency and accuracy of the medical diagnosing process. Predictions from
machine-learning models already drive important healthcare decisions for over 70 million people
across the United States[7]. However, there is reason to be cautious about assuming that the gen-
eralization of these models can be applied universally to all populations. Data-driven algorithms
used in the criminal sentencing process, for example, have already shown evidence of negatively
and disproportionately targeting defendants from low-income black communities due to biases in-
herent to the data used to train these predictive models[1]. Considering the fact that health care
delivery already varies considerably by race, it is plausible to suspect that similar inequalities might
be reflected in the decisions of machine-learning algorithms trained on historical data that lacks
awareness and insight into certain populations.
The scope of this paper will be centered around understanding the accuracy, applicability, and fair-
ness of a simple prediction model, Tangri[10], commonly used to predict imminent risk of kidney
failure. We compare this model, with another model developed using a larger population and more
comprehensive variable sets derived from Electronic Health Records (EHR), and discuss differences
in performance, applicability, and generalization. This understanding will help clinical safety pro-
fessionals critically appraise predictive kidney disease models from a quality perspective.
In particular, we focus on understanding whether each of the two predictive models are accurate
across all populations. If not, what populations are being overlooked by each model? If we start
automatic screening and interventions based on features needed to compute Tangri score, which
populations will be excluded? How does a new model trained with more comprehensive variables
compare to the traditional models commonly used in today’s practice? Does more sophisticated
machine learning make healthcare operations more or less biased?
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2 Background and Related Works
The Tangri baseline model [10] is a simple logistic regression model, designed to predict the risk
of progression towards kidney failure for patients with CKD stages 3 to 5. It has been widely
adapted for the US and non-US population [9]. A basic Tangri score relies on age, gender, estimated
glomerular filtration rate (eGFR) and urine Albumin to Creatinine ratio (ACR) tests to compute
the risk of kidney failure. This is currently the leading model that provides hospitals and other
health care providers with a method of generating a risk assessment for kidney failure and perform
early interventions [4]. However, it is unclear if large scale automatic screening methods based
on this model are applicable to all high-risk patients, and/or whether certain sub-populations are
excluded from the benefits of screening either due to lack of available eGFR or ACR tests, or due
to low predictive performance of the model. This presents the feasible possibility of overlooking
potentially high-risk patients and missing crucial opportunities for early intervention.
However, machine learning models using Electronic Health Records (EHR), have recently emerged
as an alternative to traditional risk prediction modeling, and provide more expressive and sophis-
ticated methodologies for predicting future risk of kidney failure [11, 8, 3]. These models can
simultaneously find surrogate variables when either of eGFR or ACR is missing, and combine all
predictive variables to compute the probability of progression to kidney failure. While more ex-
pressive models have been criticized for their lack of generalization and performance on minority
populations, there are very few studies that expand upon the analysis and comparison of industry
standard models and models that are more advanced or accurate.
Another closely related work, Framingham[6], addressed concerns about a commonly used risk
score for cardiovascular events. It showed that the presence of atherosclerotic disease interacted
differently between race and ethnic groups[2]. They suggested that factors such as age or blood
pressure should be weighed differently in order to retain predictive performance for different racial
and ethnic backgrounds. We explore this topic in the context of kidney failure.
3 Methods
3.1 Development Cohort
The development cohort was compiled from the electronic health records (EHR) of 1.6 million
patients who received care at NYU Langone Medical Center. For each patient, we used all demo-
graphics, disease history, lab results, and procedures time series between 2014 to 2018, and focused
on the set of patients who do not have kidney failure yet at the time of prediction.
Kidney failure was defined as observing at least two instances of any of the following
ICD-10 codes (I953, R880, T81502A, T81502D, T81502S, T81512A, T81512D, T81512S,
T81522A, T81522D, T81522S, T81532A, T81532D, T81532S, T81592A, T81592D, T81592S,
T8241XA, T8241XD, T8241XS, T8242XA, T8242XD, T8242XS, T8243XA, T8243XD,
T8243XS, T8249XA, T8249XD, T8249XS, T85611A, T85611D, T85611S, T85621A, T85621D,
T85621S, T85631A, T85631D, T85631S, T85691A, T85691D, T85691S, T8571XA, T8571XD,
T8571XS, Y622, Y841, Z4901, Z4902, Z4931, Z4932, Z9115, Z940, Z992), or dialysis or kid-
ney transplant procedure codes CPTs (G0257, 36902, 36903, 36904, 36905, 36906, 90940, 99512,
90918, 90945). Our analysis was limited to patients who did not have kidney failure by 2016/4/1.
The task was to evaluate, based on patient data between 2015/1/1 to 2016/1/1, which patients will
proceed to have kidney failure between 2016/4/1 to 2017/4/1.
3.2 Training and Validation Cohort
We included 183,490 patients in training set for our model, and 324,685 patients were included in
our validation set. Of these patients without renal failure, 98 patients in the training set, and 166
patients in the validation set proceeded to have renal failure between 2016/4/1 to 2017/4/1.
3.3 Variables for building model from EHR
For each patient, we used a total of 28,561 variables, derived from demographics, disease diagnosis,
procedures and lab values observed between 2015/1/1 to 2016/1/1. We aggregated each patient’s
one year of EHR data by taking the total count of each disease and procedure observations, and
maximum of each lab result observed in that year. We then binned all the non-binary data including
age. Lab value bins were defined according to the standard deviation of the normalized value (if
observed). Age was binned into 10 year spans. Diseases and procedures were binned into >0, >2,
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and >10 observations. After this pre-processing step, we only kept features that were observed in at
least 10 patients in the training set (of 183,490 patients). This, lead to 28561 total variables.
3.4 Machine Learning Model
To build our model, We used L1-regularized logistic regression model[5] to train a prediction model
on the training set. We tuned the regularization parameter between values of 0.0001, 0.001, 0.002,
0.005, 0.007, and 0.01, and report results on our validation set. We used weighted log loss, to deal
with our unbalanced data.
3.5 Computation of Tangri Scores
Tangri score in its simplest form requires age, gender, eGFR and Albumin to Creatinine ratio(ACR).
For eGFR, we used any of the following labs we had observed between 2015/1/1 to 2016/1/1 :
Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma (MDRD
or Schwartz method) which included any of LOINC codes 33914-3, 48642-3, 48643-1, 50210-4,
50384-7, 62238-1, 69405-9.
For ACR, we used any of the lab measurements corresponding to Albumin/Creatinine [Ratio] in
Urine, LOINC codes 32294-1, 14585-4, 30000-4, 30001-2, 32294-1, 59159-4, 76401-9, 77253-3,
77254-1, 9318-7, 44292-1, 14959-1, 14958-3, 13705-9, 9318-7, 58447-4. The unit of these labs are
taken into account (either mg/L or molar). If we have multiple labs for either eGFR or ACR, as long
as the labs were in comparable unit, we take the maximum value of all of them.
Once we selected the age, gender, eGFR and ACR, we used the following formula to compute the
probability of kidney failure according to original 4-variable Tangri score[10]:
PTangri(RenalFailure) = 1− 0.9751S
where S = exp(−0.2201× (age/10−7.036)+0.2467× (male−0.5642)−0.5567× (eGFR/5−
7.222) + 0.4510× (logACR− 5.137))
If a patient does not have eGFR or ACR, they will not get a Tangri score. This is the basis for
our analysis to understand how many patients qualify for measuring Tangri, and how many patients
(even if high-risk) will not be able to have a Tangri score.
4 Results
Table 1 includes the statistics of the total number of patients under various sub-populations, who
qualified or did not qualify for Tangri, as well as how many of them proceeded to have renal failure.
All the patients qualified for our model. Results are reported on the validation set.
Cohort Patients Tangri Eligibles Tangri-Eligible Tangri non-Elig
(had RF) (had RF) Percentage (had RF)
Full validation set 324685 (166) 7681 (8) 2.4% 317004 (158)
Gender: Female 198362 (64) 4116 (2) 2.1% 194246 (62)
Gender: Male 126305 (102) 3565 (6) 2.8% 122740 (96)
Race: African American 30348 (33) 1220 (2) 4.0% 29128 (31)
Race: Asian 4621 (8) 118 (0) 2.6% 4503 (8)
Race: White 199665 (71) 4103 (3) 2.1% 195562 (68)
Age: 20-30 29220 (3) 164 (0) 0.6% 29056 (3)
Age: 30-40 39068 (13) 444 (0) 1.1% 38624 (13)
Age: 40-50 44836 (20) 956 (0) 2.1% 43880 (20)
Age: 50-60 57845 (27) 1805 (0) 3.1% 56040 (27)
Age: 60-70 57780 (57) 2150 (5) 3.7% 55630 (52)
Age: 70-80 36951 (26) 1473 (2) 4.0% 35478 (24)
Age: 80-90 17000 (18) 603 (1) 3.5% 16397 (17)
Table 1: Patients with or without Renal Failure (RF) who did or did not qualified for Tangri scoring
We note that overall, significantly more patients who did progress to Renal Failure, did not have
the lab measurements needed (eGFR and ACR) to allow them to be scored by Tangri method. This
could be due to them having the tests done elsewhere, or not being managed by a nephrologist. All
high-risk patients under the age of 60 in our cohort would have been missed if Tangri scoring were
to be applied to EHR data retrospectively and automatically. In Table 2, we show the performance
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Cohort AUC AUC of Tangri on AUC of M on AUC of M on
of Tangri-eligible Tangri-eligible Tangri-non
M patients patients -eligible patients
Full validation set 0.88 0.86 0.836 0.886
Gender: Female 0.877 0.48 0.55 0.893
Gender: Male 0.871 0.992 0.929 0.872
Race: African American 0.885 0.554 0.787 0.909
Race: Asian 0.876 N/A N/A 0.874
Race: White 0.848 0.995 0.939 0.848
Age: 20-30 0.55 N/A N/A 0.549
Age: 30-40 0.788 N/A N/A 0.787
Age: 40-50 0.922 N/A N/A 0.92
Age: 50-60 0.944 N/A N/A 0.943
Age: 60-70 0.846 0.756 0.719 0.876
Age: 70-80 0.853 0.993 0.968 0.842
Age: 80-90 0.891 0.992 0.997 0.883
Table 2: Performance of our proposed model(M) in predicting Renal Failure compared with Tan-
gri model on different sub-populations. N/A indicates that there were not enough Tangri-eligible
patients to evaluate the AUC. All AUCs are measured on the validation set.
of Tangri and our model for each sub-population. We observe that our model has above a 0.84
AUC in all sub-populations, except the younger cohort (age < 40) which both Tangri and our model
performed poorly on. We also observe that both models severely under-perform for the subset of
female patients who had eGFR and ACR, although for the broader female cohort, including patients
who did not participate in these tests, we see that our model achieves a 0.89 AUC. In addition, the
Tangri model under-performs for the African American sub cohort, whereas our proposed model
achieves an AUC of 0.787 on African American patients who had eGFR and ACR, and 0.885 for the
general African American cohort.
5 Discussions and Conclusion
Renal failure is devastating. Treatment options for renal failure include dialysis, a procedure that
is required indefinitely three times a week, or kidney transplant, which is extremely invasive. Pre-
venting renal failure brings years of quality life to patients and early intervention often increases
the probability of successful treatments. Currently, to screen for high-risk patients, Tangri, which
needs eGFR (a blood test) and ACR (a Urine test) is recommended to predict the risk of renal failure
within 2 years. As we saw in Result section Table 1, these tests are not available for over 95% of
patients who truly progressed to Renal failure. In a general patient cohort, the percentage of patients
who already had these tests measured were even lower: 2.3%. Further still, we saw that this ratio
becomes even lower in younger populations like women and several other sub-cohorts. If we were to
screen all patients based on the traditional Tangri score, the measurement of eGFR and ACR alone
would incur significant financial and resource costs. On the other hand we showed that by using
readily available electronic health records instead of two very specific, but often unavailable tests,
we can scale screening to all populations. As we saw in Table 2, the performance of the new model
in predicting renal failure remains high for sub-cohorts that the Tangri risk score proved to be very
precise (i.e Male, white, old). However, our model increases the performance of risk prediction for
rest of the sub-cohorts (women, African American, Asian, and younger patients). Several available
techniques can further improve the quality and fairness of the model across all sub-cohorts, which
is part of our ongoing and future work.
In conclusion, in this paper, we focused on a well-established regression model (Tangri) and com-
pared it with a modernized and larger model trained on EHR data. Our results indicated that (1) A
model such as Tangri is already heavily biased and should be significantly scrutinized for large-scale
screening due to its lack of inclusively, and (2) Machine learning models trained on a diverse cohort
with access to more variables improve prediction performance for all sub-populations. This prelimi-
nary analysis is a step towards understanding and quantifying bias of status quo prediction methods,
compared to stronger machine learning models.
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